Search - tctmd.com

Displaying 581 - 600 of 836

Sort: Relevancy | Date

News Daily News

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

L.A. McKeown

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

July 08, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

News Daily News

支架内新生内膜动脉粥样硬化与未治疗主动脉中的斑块进展有联系

June 16, 2015

News Daily News

伴随着新一代 DES 投入应用，超长支架与不良事件有关

Nicole Lou

June 16, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Daily News

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

L.A. McKeown

June 15, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

Presentation Fellows 2015

Stent Thrombosis and Restenosis

Presenter: Duane S. Pinto, Tamim Nazif, Ajay J. Kirtane

May 16, 2015

News Daily News

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

Todd Neale

April 29, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

Advertisement

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

FDA approves new antiplatelet drug used during heart procedure

支架内新生内膜动脉粥样硬化与未治疗主动脉中的斑块进展有联系

伴随着新一代 DES 投入应用，超长支架与不良事件有关

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

Evolving DES Technology May Benefit Diabetic Patients

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Stent Thrombosis and Restenosis

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

FDA Panel Backs Cangrelor for Use in PCI

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content